Oncology - CUHK Research Portal - CONVERIS Research Information System

Go to Header Go to Navigation Go to Content Go to Footer

Oncology

Research Area»Health SciencesInternal medicine related»

Code: 0222

Most Relevant People

CHAN, Tak Cheung Anthony

CHEUNG, Yin Ting

LING, Cheuk Chi

LOONG, Herbert Ho Fung

MA, Buig Yue Brigette

MOK, Tony Shu Kam

Related People

MOELLER, Andreas

Most Relevant Research Outputs

Go to first page

Go to previous page

1 of 56

Go to next page

Go to last page

1195TiP HERTHENA-Lung02: A randomized phase III study of patritumab deruxtecan vs platinum-based chemotherapy in locally advanced or metastatic EGFR-mutated NSCLC after progression with a third-generation EGFR TKI (2022)

1197P First-line lorlatinib versus crizotinib in ALK-positive non-small cell lung cancer: Asian subgroup analysis of CROWN (2021)

1199P Dose modification for the management of CNS adverse events in the phase III CROWN study of lorlatinib in non-small cell lung cancer (NSCLC) (2021)

1281O Atezolizumab (atezo) vs platinum-based chemo in blood-based tumour mutational burden-positive (bTMB+) patients (pts) with first-line (1L) advanced/metastatic (m)NSCLC: Results of the Blood First Assay Screening Trial (BFAST) phase III cohort C (2021)

1805P Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer (2021)

362P Intracranial activity of dacomitinib in treatment naïve advanced EGFR mutated non-small cell lung cancer (NSCLC): Prespecified subgroup analysis of the ATORG-003 trial (2022)

507O EXCLAIM-2: Phase III trial of first-line (1L) mobocertinib versus platinum-based chemotherapy in patients (pts) with epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)+ locally advanced/metastatic NSCLC (2023)

5MO Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDON (2022)

96P Transbronchial microwave ablation: Important role in the battle of lung preservation for multifocal lung primaries or metastases (2022)

979P Long-term intracranial safety and efficacy analyses from the phase III CROWN study (2022)

Related Research Outputs

Go to first page

Go to previous page

1 of 6

Go to next page

Go to last page

A 3D organoid model reveals that ovarian tumour growth is promoted by Lymphotoxin overexpression (2021)

A review on the relationship of mast cells and macrophages in breast cancer - Can herbs or natural products facilitate their anti-tumor effects? (2021)

A scoping review of nausea, vomiting and retching measurement methods in children with cancer (2022)

Association between Body Mass Index at Diagnosis and Outcomes in Chinese Children with Newly Diagnosed Acute Lymphoblastic Leukemia (2022)

Association between potential supplement–drug interactions and liver diseases in patients with cancer: A large prospective cohort study (2023)

Association of supplement use with all-cause and cause-specific mortality in cancer: UK Biobank study (2022)

Awareness of diagnosis, treatment and risk of late effects in Chinese survivors of childhood cancer in Hong Kong (2021)

Awareness of treatment-related health risks and health-protective behavior among Chinese survivors of childhood cancer (2020)

Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma (2023)

Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives (2020)